Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Shi

Showing results (1301-1310 of 1,428) with videos related to

Pageof 143
Sort By:
Cancer Immunology, Immunotherapy : CII|July 25, 2019
Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomyMeng-Xin Tian, Yu-Fu Zhou, Wei-Feng Qu, et al.
Cancer Research|June 20, 2012
CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinomaQiang Gao, Ying-Jun Zhao, Xiao-Ying Wang, et al.
Plos One|March 21, 2012
Human remains from the Pleistocene-Holocene transition of southwest China suggest a complex evolutionary history for East AsiansDarren Curnoe, Ji Xueping, Andy I R Herries, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2025
Multiorgan transcriptomics in mice identifies immunoglobulin heavy constant mu (<i>Ighm</i>) as a tissue-level aging biomarkerFan-Qian Yin, Xia-Yan Wang, Yong-Xuan Li, et al.
The Journal of Invasive Cardiology|October 2, 2007
Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary interventionXin-Chun Yang, Yu Liu, Le-Feng Wang, et al.
Carcinogenesis|June 12, 2010
Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X proteinDoriane A Gouas, Hong Shi, Agnès H Hautefeuille, et al.
Oncotarget|December 17, 2014
PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinomaWei-Ren Liu, Meng-Xin Tian, Liu-Xiao Yang, et al.
Cells|September 9, 2022
Sex-Dependent Role of Adipose Tissue HDAC9 in Diet-Induced Obesity and Metabolic DysfunctionBrandee Goo, Samah Ahmadieh, Abdalrahman Zarzour, et al.
Signal Transduction and Targeted Therapy|January 26, 2022
Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrenceShao-Lai Zhou, Zheng-Jun Zhou, Cheng-Li Song, et al.
BMC Cancer|July 12, 2020
Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysisWei-Ren Liu, Meng-Xin Tian, Chen-Yang Tao, et al.
Pageof 143

Showing results (1301-1310 of 1,428) with videos related to

Sort By:
Pageof 143
Cancer Immunology, Immunotherapy : CII|July 25, 2019
Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomyMeng-Xin Tian, Yu-Fu Zhou, Wei-Feng Qu, et al.
Cancer Research|June 20, 2012
CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinomaQiang Gao, Ying-Jun Zhao, Xiao-Ying Wang, et al.
Plos One|March 21, 2012
Human remains from the Pleistocene-Holocene transition of southwest China suggest a complex evolutionary history for East AsiansDarren Curnoe, Ji Xueping, Andy I R Herries, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2025
Multiorgan transcriptomics in mice identifies immunoglobulin heavy constant mu (<i>Ighm</i>) as a tissue-level aging biomarkerFan-Qian Yin, Xia-Yan Wang, Yong-Xuan Li, et al.
The Journal of Invasive Cardiology|October 2, 2007
Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary interventionXin-Chun Yang, Yu Liu, Le-Feng Wang, et al.
Carcinogenesis|June 12, 2010
Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X proteinDoriane A Gouas, Hong Shi, Agnès H Hautefeuille, et al.
Oncotarget|December 17, 2014
PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinomaWei-Ren Liu, Meng-Xin Tian, Liu-Xiao Yang, et al.
Cells|September 9, 2022
Sex-Dependent Role of Adipose Tissue HDAC9 in Diet-Induced Obesity and Metabolic DysfunctionBrandee Goo, Samah Ahmadieh, Abdalrahman Zarzour, et al.
Signal Transduction and Targeted Therapy|January 26, 2022
Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrenceShao-Lai Zhou, Zheng-Jun Zhou, Cheng-Li Song, et al.
BMC Cancer|July 12, 2020
Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysisWei-Ren Liu, Meng-Xin Tian, Chen-Yang Tao, et al.
Pageof 143